HPC Biosciences Limited announced unaudited earnings results for the six months ended September 30, 2015. For the six months, the company reported net sales of INR 1,382,644.5 million against INR 1,446,238.8 million a year ago. Profit from operations before other income, interest and exceptional item was INR 415,062.149 million against INR 466,888.762 million a year ago.

Profit from ordinary activities before tax was INR 415,062.149 million against INR 466,888.762 million a year ago. Net profit for the period was INR 390,391.651 million or INR 0.02 basic and diluted per share before and after extraordinary items against INR 448,497.36 million or INR 0.28 basic and diluted per share before and after extraordinary items a year ago.